Your browser doesn't support javascript.
loading
Retinoblastoma pathway deregulatory mechanisms determine clinical outcome in high-grade serous ovarian carcinoma.
Milea, Anca; George, Sophia H L; Matevski, Donco; Jiang, Haiyan; Madunic, Mary; Berman, Hal K; Gauthier, Mona L; Gallie, Brenda; Shaw, Patricia A.
Affiliation
  • Milea A; 1] Campbell Family Institute for Breast Cancer Research, Toronto, ON, Canada [2] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada [3] Princess Margaret Cancer Centre, Toronto, ON, Canada [4] Department of Pathology, University Health Network, Toronto, ON
  • George SH; 1] Campbell Family Institute for Breast Cancer Research, Toronto, ON, Canada [2] Princess Margaret Cancer Centre, Toronto, ON, Canada [3] Department of Pathology, University Health Network, Toronto, ON, Canada.
  • Matevski D; 1] Department of Pathology, University Health Network, Toronto, ON, Canada [2] Impact Genetics, Toronto, ON, Canada.
  • Jiang H; 1] Princess Margaret Cancer Centre, Toronto, ON, Canada [2] Department of Pathology, University Health Network, Toronto, ON, Canada.
  • Madunic M; 1] Princess Margaret Cancer Centre, Toronto, ON, Canada [2] Department of Pathology, University Health Network, Toronto, ON, Canada.
  • Berman HK; 1] Campbell Family Institute for Breast Cancer Research, Toronto, ON, Canada [2] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada [3] Princess Margaret Cancer Centre, Toronto, ON, Canada [4] Department of Pathology, University Health Network, Toronto, ON
  • Gauthier ML; 1] Campbell Family Institute for Breast Cancer Research, Toronto, ON, Canada [2] Princess Margaret Cancer Centre, Toronto, ON, Canada [3] Department of Pathology, University Health Network, Toronto, ON, Canada [4] Department of Medical Biophyics, University of Toronto, Toronto, ON, Canada.
  • Gallie B; 1] Princess Margaret Cancer Centre, Toronto, ON, Canada [2] Department of Pathology, University Health Network, Toronto, ON, Canada [3] Impact Genetics, Toronto, ON, Canada [4] Department of Medical Biophyics, University of Toronto, Toronto, ON, Canada [5] Department of Molecular Genetics, Universit
  • Shaw PA; 1] Campbell Family Institute for Breast Cancer Research, Toronto, ON, Canada [2] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada [3] Princess Margaret Cancer Centre, Toronto, ON, Canada [4] Department of Pathology, University Health Network, Toronto, ON
Mod Pathol ; 27(7): 991-1001, 2014 Jul.
Article in En | MEDLINE | ID: mdl-24336157
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Retinoblastoma Protein / Cystadenocarcinoma, Serous Type of study: Prognostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Mod Pathol Journal subject: PATOLOGIA Year: 2014 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Retinoblastoma Protein / Cystadenocarcinoma, Serous Type of study: Prognostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Mod Pathol Journal subject: PATOLOGIA Year: 2014 Document type: Article